| Financier | Commitments |
|---|---|
| IDA Credit | 5.00 |
Djibouti COVID-19 Response
Abstract*
The project includes four components.
1. Emergency COVID-19 Response: to slow down and limit as much as possible the spread of COVID-19 in the country. This will be achieved through providing immediate support to enhance case detection, confirmation, recording and reporting, as well as contact tracing and risk assessment and mitigation.
2. Strengthening Overall Healthcare Services and Clinical Capacity to Respond to COVID-19: to strengthen essential... Show More
Development Objective
To prevent, detect and respond to the threat posed by COVID-19 and strengthen national systems for public health preparedness
Key Details
Project Details
P173807
Closed
Ana Besarabic
The Republic of Djibouti
March 24, 2020
(as of board presentation)
April 2, 2020
April 9, 2020
US$ 5.00 million
Ministry of Health
2020
US$ 5.00 million
N/A
September 29, 2023
June 30, 2023
No
BANK APPROVED
Finances
Financing Plan (US$ Millions)
Total Project Financing (US$ Millions)
| Product Line | IBRD/IDA |
|---|---|
| IBRD Commitment | N/A |
| IDA Commitment | 5.00 |
| IBRD + IDA Commitment | 5.00 |
| Lending Instrument | |
|---|---|
| Grant Amount | N/A |
| Total Project Cost** | 5.00 |
Summary Status of World Bank Financing (US$ Millions) as of February 28, 2025
No data available.
| Period | Financier | Transaction Type | Amount (US$) |
|---|---|---|---|
| May 13, 2020 | IDA-66000 | Loan Disb | 562,500.00 |
| Oct 1, 2023 | IDA-66000 | Int Charges | 26.55 |
| Oct 19, 2020 | IDA-66000 | Int Charges | 5,235.88 |
| Oct 19, 2020 | IDA-66000 | Int Charges | 5,235.88 |
| Oct 1, 2021 | IDA-66000 | Int Charges | 50.76 |
| Mar 29, 2022 | IDA-66000 | Loan Disb | 523,953.34 |
| Apr 11, 2022 | IDA-66000 | Int Charges | 10,553.72 |
| Apr 11, 2022 | IDA-66000 | Int Charges | 10,553.72 |
| Apr 12, 2021 | IDA-66000 | Int Charges | 502.32 |
| Apr 12, 2021 | IDA-66000 | Int Charges | 502.32 |
| Apr 12, 2021 | IDA-66000 | Int Charges | 10,425.58 |
| Apr 12, 2021 | IDA-66000 | Int Charges | 10,425.58 |
| Sep 10, 2020 | IDA-66000 | Loan Disb | 1,125,000.00 |
| Mar 19, 2021 | IDA-66000 | Loan Disb | 187,499.98 |
| Apr 13, 2023 | IDA-66000 | Loan Disb | -52,288.00 |
| Apr 18, 2023 | IDA-66000 | Int Charges | 14,218.28 |
| Apr 18, 2023 | IDA-66000 | Int Charges | 14,218.28 |
| Oct 31, 2022 | IDA-66000 | Int Charges | 11,616.74 |
| Oct 31, 2022 | IDA-66000 | Int Charges | 11,616.74 |
| Dec 22, 2022 | IDA-66000 | Loan Disb | 1,047,906.10 |
| Apr 1, 2022 | IDA-66000 | Int Charges | 125.10 |
| Apr 1, 2022 | IDA-66000 | Int Charges | 125.10 |
| Oct 5, 2021 | IDA-66000 | Int Charges | 10,930.13 |
| Oct 5, 2021 | IDA-66000 | Int Charges | 10,930.13 |
| Oct 1, 2021 | IDA-66000 | Int Charges | 50.76 |
| Apr 9, 2024 | IDA-66000 | Int Charges | 18,314.14 |
| Apr 9, 2024 | IDA-66000 | Int Charges | 18,314.14 |
| Apr 1, 2024 | IDA-66000 | Int Charges | 96.95 |
| Apr 1, 2024 | IDA-66000 | Int Charges | 96.95 |
| Nov 1, 2023 | IDA-66000 | Loan Disb | 6,932.99 |
| Sep 11, 2023 | IDA-66000 | Loan Disb | 77,040.00 |
| Aug 2, 2023 | IDA-66000 | Loan Disb | 61,290.00 |
| Aug 2, 2023 | IDA-66000 | Loan Disb | 119,540.00 |
| May 30, 2023 | IDA-66000 | Loan Disb | 399,000.00 |
| Oct 1, 2022 | IDA-66000 | Int Charges | 187.69 |
| Oct 1, 2022 | IDA-66000 | Int Charges | 187.69 |
| Apr 1, 2023 | IDA-66000 | Int Charges | 381.88 |
| Apr 1, 2023 | IDA-66000 | Int Charges | 381.88 |
| Apr 2, 2020 | IDA-66000 | Loan Commitment | 5,000,000.00 |
| Oct 23, 2023 | IDA-66000 | Int Charges | 16,985.05 |
| Oct 23, 2023 | IDA-66000 | Int Charges | 16,985.05 |
| Oct 1, 2023 | IDA-66000 | Int Charges | 26.55 |
| Apr 16, 2020 | IDA-66000 | Loan Disb | 1,000,000.00 |
Ratings
IMPLEMENTATION RATINGS
| Name | Review | Date |
|---|---|---|
| Progress towards achievement of PDO | Satisfactory | 2023-10-06 |
| Monitoring and Evaluation | Satisfactory | 2023-10-06 |
| Overall Implementation Progress (IP) | Satisfactory | 2023-10-06 |
| Project Management | Satisfactory | 2023-10-06 |
| Procurement | Moderately Satisfactory | 2023-10-06 |
| Financial Management | Moderately Satisfactory | 2023-10-06 |
COMPLETION RATINGS
No data available.
INDEPENDENT EVALUATION RATINGS
No data available.
Results Framework
PROJECT DEVELOPMENT OBJECTIVE INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of suspected cases of COVID-19 reported and investigated based on national guidelines Value 0.00 547666.00 500000.00 Date February 29, 2020 April 30, 2023 March 31, 2023 Comment Number of designated laboratories with COVID-19 diagnostic equipment, test kits, and reagents Value 1.00 7.00 10.00 Date February 29, 2020 June 30, 2023 March 31, 2023 Comment
INTERMEDIATE RESULTS INDICATORS
| INDICATOR | BASELINE | CURRENT | TARGET |
|---|
Number of health staff trained in infection prevention and control per MoH-approved protocols Value 50.00 493.00 2000.00 Date February 29, 2020 April 30, 2023 March 31, 2023 Comment Percentage of acute healthcare facilities with triage capacity Value 0.00 100.00 100.00 Date February 29, 2020 April 30, 2023 March 31, 2023 Comment M&E system established to monitor COVID-19 preparedness and response plan Value No Yes Yes Date February 29, 2020 December 30, 2022 March 31, 2023 Comment Percentage of health and non-health workers expressing satisfaction with training on case definition, management, infection prevention and control Value 0.00 96.77 80.00 Date October 8, 2020 April 30, 2023 March 31, 2023 Comment Percentage of grievances that are addressed and responded to within a timeline that has been specified and publicly communicated bythe project Value 0.00 85.71 60.00 Date October 8, 2020 June 19, 2023 March 31, 2023 Comment